email_pop up_pop
X

EMAIL US

X
up_inner

UNITARY PATENT

In 2012 Member States and the European Parliament agreed on the "patent package" - a legislative initiative consisting of two...

find out more

Patent Issues Spring 2015 - Bio Special Edition

patent issues Spring 2015
Bio Special Edition

Highlights this Issue

  • Patentablity of Parthenotes in Europe

  • Broccoli II and Tomatoes II

  • Pan-European Declaration of Non-Infringement: Actavis V Eli Lilly

  • When is a Drug Prescribed "for" Pain?
Download Issue (PDF)
in this issue
featured

Patentability of Parthenotes in Europe

On 23 December 2014, the Court of Justice of the European Union (CJEU) issued its opinion on the patentability of parthenotes. This opinion was given in response to a ref...

Read More

Broccoli II and Tomatoes II

The EPO Enlarged Board of Appeal (EBA) has now issued a decision for the second referrals in the Broccoli and Tomato cases (G2/12 and G2/13). Both of the first and second...

Read More

Pan-European Declaration of Non-Infringement: Acta...

On 27th November 2014, the Patents Court handed down a ruling which could significantly affect the way litigation is conducted in Europe. It was held that a declaration o...

Read More

When is a Drug Prescribed "for" Pain?

A battle has been going on in the UK courts between Warner-Lambert, owner of a patent for a second medical use for pregabalin, and Actavis, a generic manufacturer intent ...

Read More
news

Patentability of Parthenotes in Europe

On 23 December 2014, the Court of Justice of the European Union (CJEU) issued its opinion on the patentability of parthenotes. This opinion was given in response to a ref...

Read More

Broccoli II and Tomatoes II

The EPO Enlarged Board of Appeal (EBA) has now issued a decision for the second referrals in the Broccoli and Tomato cases (G2/12 and G2/13). Both of the first and second...

Read More

Pan-European Declaration of Non-Infringement: Acta...

On 27th November 2014, the Patents Court handed down a ruling which could significantly affect the way litigation is conducted in Europe. It was held that a declaration o...

Read More

UK Bolar Exemption Broadened to include Novel Drug...

The “Bolar exemption” is an exception to the exclusive right granted by a patent, permitting use of patented products in experiments for the purpose of obtaining regulato...

Read More

Comparison of Bolar Exemption Across Europe

We now have various flavours of Bolar exemption in Europe, which can be categorised by (a) acts exempted, (b) whether the testing is for marketing authorisation in the EU...

Read More

CJEU Review of Bolar Exemption Withdrawn

The Düsseldorf Court of Appeal referred certain questions to the CJEU for a preliminary ruling as to whether, in the case of a generic company seeking to shelter under th...

Read More

When is a Drug Prescribed "for" Pain?

A battle has been going on in the UK courts between Warner-Lambert, owner of a patent for a second medical use for pregabalin, and Actavis, a generic manufacturer intent ...

Read More

New Option to Pay Additional Search Fees at the Eu...

Rule 164 EPC came into force as of 1 November 2014, such that when an EPO search examiner carries out a supplementary search of a PCT application upon entry to the Europe...

Read More

Swiss Claims in Europe

For many years, patent offices in Europe and the courts have sought to grant and uphold patent protection for inventions which are made through the discovery of the new u...

Read More